Public Webinar: Transforming Real-World Evidence with AI: From Data to Decisions
Public Webinar: From Policy to Practice: EHDS Implementation to Support Better Real-World Evidence for HTA/Payers
The 9 April RWE4Decisions Webinar “From Policy to Practice: EHDS Implementation to Support Better Real-World Evidence for HTA/Payers” brought together a vibrant community of over 200 participants to discuss how the European Health Data Space (EHDS) could generate robust real-world evidence (RWE) to support better informed, more timely HTA/Payers decisions. The discussion focused on practical […]
Public Webinar: HTA/Payer Collaboration in the Nordics: The Role of Real-World Evidence
On the 23rd of October, between 15:00-16:30 CEST, RWE4Decisions hosted its last webinar for 2024: “HTA/Payer Collaboration in the Nordics – The Role of Real-World Evidence”. Speakers explored the creation and operation of the Joint Nordic HTA Bodies (JNHB) collaboration, how it evolved from FINOSE to JNHB, and how joint reports are taken up locally.
Public Webinar: Can Endpoints from Digital Technology Provide Meaningful Outcomes for HTA?
On 25 June 2024, RWE4Decisions hosted a webinar titled “Can endpoints from digital technology provide meaningful outcomes for Health Technology Assessment (HTA)?” At the webinar, speakers discussed how patient-generated health data could be analyzed to support Health Technology Assessment (HTA) bodies and Payers, delving into issues such as app governance models, the use of AI, […]
Stakeholder Actions to Generate Better Real-World Evidence for HTA and Payers
The 26th of March 2024 RWE4Decisions webinar discussed the revision of the 2020 paper “Real-world Evidence to Support Payer/HTA Decisions about Highly Innovative Technologies in the EU – Actions for Stakeholders”, available here. Together with the RWE4Decisions Learning Network, a new set of Actions for each stakeholder group has been drafted and presented at the webinar. […]
RWE over the lifecycle of ATMPs to meet the HTA (Regulation) Needs
Join us on 10 October for the RWE4Decisions webinar on how RWE over the lifecycle of ATMPs could support the EU joint HTA work. You will hear from Prof Ana Hidalgo-Simon, who will set the scene on the clinical and regulatory context for ATMPs in the EU. A multi-stakeholder panel will then follow, representing the […]
Beating Cancer with Highly Innovative Technologies – What’s the role of RWE?
Join us on 18 April for the first webinar on using RWE to demonstrate the value of cancer treatments. A keynote address will outline the EU policy context in terms of the Beating Cancer Plan. A panel including policy, clinical, patient, industry and HTA experts will then discuss the opportunities and challenges of RWE generation […]
Public webinar series | Supporting HTA/Payer decision-making: Health data initiatives in Germany
On 21 September 2022, the RWE4Decisions community gathered for a multi-stakeholder discussion on HealthData in Germany, with a focus on the routine data collection practice (AbD) at the Federal Joint Committee (G-BA). The panel featured representation of HTA bodies, patients, insurers and industry.
Public Webinar Series | Supporting HTA/Payer decisions making: National health data initiatives in Finland, Spain and France
On 21 September 2022, the RWE4Decisions community gathered for a multi-stakeholder discussion on HealthData in Germany, with a focus on the routine data collection practice (AbD) at the Federal Joint Committee (G-BA). The panel featured representation of HTA bodies, patients, insurers and industry.
Towards Establishing an EU Real-World Evidence Generation Action Plan for Better Healthcare Systems & Patient Outcomes
The need for an EU Real-World Evidence (RWE) Generation Action Plan was a key conclusion from the 2020 RWE4Decisions Conference held under the auspices of the German EU Presidency. This call was taken up in the June EPSCO Council Conclusions on Access to Medicines under the Portuguese EU Presidency.